Hanoch Rappaport
Vorstandsvorsitzender bei Provident Fund of the Hebrew University of Jerusalem Ltd.
Aktive Positionen von Hanoch Rappaport
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The Hebrew University of Jerusalem | Corporate Officer/Principal | - | - |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Vorstandsvorsitzender | 01.01.2014 | - |
| Finanzdirektor/CFO | 01.05.2005 | 01.01.2014 |
Karriereverlauf von Hanoch Rappaport
Ehemalige bekannte Positionen von Hanoch Rappaport
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 01.01.2006 | 01.11.2013 |
| ANCHIANO THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 01.01.2006 | - |
| A. Heifetz & Co. | Chief Investment Officer | - | - |
| BANK HAPOALIM B.M. | Corporate Officer/Principal | - | - |
Ausbildung von Hanoch Rappaport
| Bar-Ilan University | Undergraduate Degree |
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Masters Business Admin |
Statistik
International
| Israel | 7 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
| Masters Business Admin | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BANK HAPOALIM B.M. | Finance |
| Private Unternehmen | 4 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| A. Heifetz & Co. | |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Finance |
- Börse
- Insiders
- Hanoch Rappaport
- Erfahrung
